Skip to main content
. 2023 Dec 27;13(1):153. doi: 10.3390/jcm13010153

Table 1.

Baseline and operative characteristics of patients, aged between 40 and 65 years, with IE treated with mechanical versus biological aortic valve prostheses.

Variables Mechanical Valve
(N = 268)
Biological Valve
(N = 281)
p Value
Age (years, median [IQR]) 52.00 [45.37, 57.56] 57.00 [48.74, 62.00] <0.001
Female gender, n (%) 64 (23.9) 40 (14.2) 0.006
Hypertension, n (%) 64 (23.9) 75 (26.7) 0.510
Diabetes, n (%) 23 (8.6) 32 (11.4) 0.341
Obesity, n (%) 18 (6.7) 22 (7.8) 0.736
COPD, n (%) 13 (4.9) 16 (5.7) 0.802
Drug abuse, n (%) 14 (5.2) 13 (4.6) 0.900
Previous cardiac surgery, n (%) 8 (3.0) 14 (5.0) 0.330
LVEF (%, mean (SD)) 54.94 (8.45) 54.22 (9.47) 0.346
Peripheral arteriopathy, n (%) 8 (3.0) 13 (4.6) 0.436
Preoperative stroke, n (%) 30 (11.2) 34 (12.1) 0.843
Heart failure, n (%) 28 (10.4) 59 (21.0) 0.001
Cardiogenic shock, n (%) 13 (4.9) 27 (9.6) 0.048
Acute myocardial infarction (within 90 days), n (%) 3 (1.1) 4 (1.4) 1.000
Active endocarditis, n (%) 205 (76.5) 226 (80.4) 0.309
Preoperative MV, n (%) 8 (3.0) 28 (10.0) 0.002
Pulmonary hypertension (<50 mmHg), n (%) 15 (5.6) 19 (6.8) 0.697
CKD, n (%) 26 (9.7) 28 (10.0) 1.000
Dialysis, n (%) 11 (4.1) 11 (3.9) 1.000
IABP, n (%) 1 (0.4) 5 (1.8) 0.241
Preoperative pacemaker implantation, n (%) 2 (0.7) 6 (2.1) 0.317
NVE, n (%) 267 (99.6) 281 (100) 1.000
PVE, n (%) 1 (0.4) 0 (0.0) 1.000
Abscess, n (%) 27 (10.1) 43 (15.3) 0.088
Large vegetation (>1 cm), n (%) 121 (45.1) 102 (36.3) 0.043
Leaflet perforation, n (%) 29 (10.8) 50 (17.8) 0.027
Paravalvular leak, n (%) 1 (0.4) 1 (0.4) 1.000
CABG, n (%) 0.367
0 257 (95.9) 265 (94.3)
1 9 (3.3) 12 (4.3)
2 1 (0.4) 4 (1.4)
≥3 1 (0.4) 0 (0.0)
Logistic Euroscore (median [IQR]) 4.68 [2.78, 8.90] 6.45 [3.62, 13.61] 0.005
Cardiopulmonary bypass time (min, mean (SD)) 79.26 (33.47) 90.94 (49.47) 0.004
Aortic cross-clamp time (min, mean (SD)) 63.53 (23.62) 73.39 (34.97) 0.001

CABG, coronary artery bypass grafting; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; MV, mechanical ventilation; NVE, native valve endocarditis; PVE, prosthetic valve endocarditis.